Ligand validation:4TNW

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4TNW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4TNW_NAG_E_401	46%	78%	0.163	0.897	0.26	0.63	-	-	0	0	100%	0.9333
4TNW_NAG_A_401	24%	64%	0.226	0.856	0.29	1.06	-	1	0	0	100%	0.9333
4TNW_NAG_B_402	22%	72%	0.25	0.867	0.26	0.8	-	-	0	0	100%	0.9333
4TNW_NAG_D_402	21%	54%	0.194	0.802	0.35	1.38	-	2	0	0	100%	0.9333
4TNW_NAG_P_401	21%	70%	0.238	0.847	0.33	0.8	-	1	0	0	100%	0.9333
4TNW_NAG_Q_402	19%	77%	0.225	0.819	0.26	0.66	-	-	0	0	100%	0.9333
4TNW_NAG_S_401	18%	56%	0.218	0.805	0.34	1.34	-	1	0	0	100%	0.9333
4TNW_NAG_C_401	17%	68%	0.265	0.844	0.39	0.85	-	1	0	0	100%	0.9333
4TNW_NAG_T_402	3%	69%	0.34	0.683	0.35	0.82	-	1	0	0	100%	0.9333
4TNV_NAG_E_401	53%	75%	0.14	0.899	0.33	0.63	-	-	0	0	100%	0.9333
3RI5_NAG_C_400	28%	40%	0.192	0.843	0.37	1.92	-	2	1	0	100%	0.9333
3RIF_NAG_E_400	8%	56%	0.35	0.817	0.46	1.2	-	2	0	0	100%	0.9333
3RHW_NAG_B_400	5%	41%	0.384	0.791	0.57	1.7	-	3	1	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.